Emerging Diseases News

BOSTON — Sub-Saharan African countries supported by the U.S. President’s Emergency Plan for AIDS Relief, or PEPFAR, tested for COVID-19 at three times the rate of non-PEPFAR nations, according to data presented at IDWeek.

A new study links some neurocognitive symptoms of long COVID to persistent SARS-CoV-2 infection in the gut, which triggers a series of reactions that lowers serotonin levels.

In a cohort of individuals with MS, a diagnosis of COVID-19 was linked to an increased risk of disability progression compared with those without, according to a presentation from ECTRIMS 2023.

People infected with COVID-19 have a higher risk of cardiovascular/cerebrovascular complications. However, researchers found that these risks can be reduced with vaccination and boosting.

BOSTON — The Infectious Diseases Society of America is focused on growing the ID workforce and increasing opportunities for its members, its new president told Healio at IDWeek.

Bavarian Nordic’s chikungunya vaccine candidate was shown to be highly immunogenic in participants across age groups, according to data presented at IDWeek.

BOSTON — An ongoing outbreak of cholera in Haiti has infected nearly 1 million people, and the situation will not improve unless action is taken, Louise Ivers, MD, MPH, FIDSA, FASTMH, told Healio at IDWeek.

BOSTON — The Infectious Diseases Society of America Foundation named Edsel Salvana, MD, DTM&H, FDCP, FIDSA, its sixth IDea Incubator Innovator of the year at IDWeek for portable HIV drug resistance testing.

BOSTON — During the Edward H. Kass Lecture at IDWeek, Louise Ivers, MD, MPH, FIDSA, FASTMH, addressed the crowd about infections, inequalities and the hope that everyone can contribute to improving health for all.

COVID-19 vaccination was associated with a reduced likelihood of long COVID among children infected with SARS-CoV-2 during the omicron wave, according to study findings presented at IDWeek.